4//SEC Filing
LONNER ANDERS 4
Accession 0001209191-10-048103
CIK 0000930184other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 8:34 PM ET
Size
5.5 KB
Accession
0001209191-10-048103
Insider Transaction Report
Form 4
LONNER ANDERS
Director
Transactions
- Disposition to Issuer
Common Stock
2010-09-28−12,766→ 0 total
Footnotes (1)
- [F1]8,881 restricted stock units disposed pursuant to merger agreement between issuer and Biovail Corporation, among others, in exchange for 24,844 Valeant Pharmaceuticals International, Inc. (formerly known as Biovail Corporation) restricted stock units, on the same terms and conditions. Remaining 3,885 restricted stock units disposed pursuant to merger agreement between issuer and, among others, Biovail Corporation in exchange for 8,145 shares of Valeant Pharmaceuticals International Inc. common stock. The fair market value of Valeant Pharmaceuticals International, Inc. on the effective date of the merger was $26.00 per share.
Documents
Issuer
VALEANT PHARMACEUTICALS INTERNATIONAL
CIK 0000930184
Entity typeother
Related Parties
1- filerCIK 0001453857
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 8:34 PM ET
- Size
- 5.5 KB